GIPR and Obesity: More recently, acute administration of a long acting GIPR agonist, GIPFA-085, acted via the ARC POMC neurons to suppress feeding and increase lipid utilization, while subchronic administration was shown to reduce body weight in diet-induced obesity mice [274].